Home/ Stocks/ KLRA

Kailera Therapeutics, Inc. Common Stock

KLRA XNAS

$12.97 +1.14 (+9.37%) ▲ 15-min delayed

Open

$12.29

High

$13.26

Low

$11.96

Volume

733.3K

Market Cap

$1.68B

About Kailera Therapeutics, Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Sector: PHARMACEUTICAL PREPARATIONS Website →

Related Market News

No specific coverage for KLRA yet. Check out our latest market news or earnings calendar.

Get KLRA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Kailera Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.